ISSN Approved Journal No: 2320-2882 | Impact factor: 7.97 | ESTD Year: 2013
Scholarly open access journals, Peer-reviewed, and Refereed Journals, Impact factor 7.97 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool) , Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI)
IJCRT Journal front page | IJCRT Journal Back Page |
Paper Title: An empirical study on ratio analysis with reference Suman and co
Author Name(s): Chandrapani D.K, REKHA GOTHE
Published Paper ID: - IJCRT21X0214
Register Paper ID - 259197
Publisher Journal Name: IJPUBLICATION, IJCRT
DOI Member ID: 10.6084/m9.doi.one.IJCRT21X0214 and DOI :
Author Country : Indian Author, India, 560009 , Bangalore , 560009 , | Research Area: Commerce All Published Paper URL: http://ijcrt.org/viewfull.php?&p_id=IJCRT21X0214 Published Paper PDF: download.php?file=IJCRT21X0214 Published Paper PDF: http://www.ijcrt.org/papers/IJCRT21X0214.pdf
Title: AN EMPIRICAL STUDY ON RATIO ANALYSIS WITH REFERENCE SUMAN AND CO
DOI (Digital Object Identifier) :
Pubished in Volume: 12 | Issue: 5 | Year: May 2024
Publisher Name : IJCRT | www.ijcrt.org | ISSN : 2320-2882
Subject Area: Commerce All
Author type: Indian Author
Pubished in Volume: 12
Issue: 5
Pages: m42-m82
Year: May 2024
Downloads: 57
E-ISSN Number: 2320-2882
This empirical study conducts a comprehensive ratio analysis to evaluate the financial performance of Bosch Ltd over a five-year period, with reference to Suman and Co as a benchmark. The analysis covers liquidity ratios, profitability ratios, leverage ratios, and other key financial metrics to gain insights into Bosch's financial health and resilience. The findings reveal a nuanced picture of Bosch's performance, highlighting both strengths and areas for improvement. One of the key findings of the study is a slight decline in Bosch's current ratio over the five-year period. This decline suggests potential liquidity challenges for the company, indicating a decreased ability to cover short-term liabilities with current assets. Such findings emphasize the importance of closely monitoring liquidity ratios to ensure the company's ability to meet its short-term obligations efficiently. Moreover, significant fluctuations in Bosch's net profit ratio were observed during the study period. These fluctuations underscore the importance of closely monitoring profitability factors and implementing strategies to maintain or improve profitability levels. By understanding the drivers behind these fluctuations, Bosch can better manage its resources and operations to enhance overall profitability. Additionally, the study identifies a decreasing trend in Bosch's quick ratio over the five-year period. The quick ratio, which excludes inventory from current assets, highlights the company's ability to meet short-term liabilities using its most liquid assets. The decreasing trend in this ratio underscores the need for Bosch to optimize its inventory management practices and implement effective liquidity strategies to maintain financial health. Despite these challenges, Bosch maintains a generally healthy liquidity position and stable capital structure. The study acknowledges the company's resilience in navigating through financial challenges and highlights its ability to maintain financial stability over the years. Based on the findings, the study proposes several recommendations for Bosch to enhance its financial performance and resilience. These recommendations include continued monitoring of financial metrics, targeted strategies to address weaknesses identified in the analysis, and leveraging strengths to capitalize on growth opportunities. Furthermore, benchmarking against industry standards, such as Suman and Co, is recommended to provide valuable insights for informed decision-making and strategic planning.
Licence: creative commons attribution 4.0
Keywords: Financial analysis, Ratio analysis, financial statements
Paper Title: Solubility Enhancement Of Fenofibtate By Solid Disperion Technique
Author Name(s): Pallavi Mahendra Girase, Vaibhavi Dattatray Ghule, Sonali Balasaheb Ghule, Dr.Sujit S. Kakade, Dr.Ashok Bhosale
Published Paper ID: - IJCRT21X0213
Register Paper ID - 259017
Publisher Journal Name: IJPUBLICATION, IJCRT
DOI Member ID: 10.6084/m9.doi.one.IJCRT21X0213 and DOI :
Author Country : Indian Author, India, 411028 , Pune, 411028 , | Research Area: Pharmacy All Published Paper URL: http://ijcrt.org/viewfull.php?&p_id=IJCRT21X0213 Published Paper PDF: download.php?file=IJCRT21X0213 Published Paper PDF: http://www.ijcrt.org/papers/IJCRT21X0213.pdf
Title: SOLUBILITY ENHANCEMENT OF FENOFIBTATE BY SOLID DISPERION TECHNIQUE
DOI (Digital Object Identifier) :
Pubished in Volume: 12 | Issue: 5 | Year: May 2024
Publisher Name : IJCRT | www.ijcrt.org | ISSN : 2320-2882
Subject Area: Pharmacy All
Author type: Indian Author
Pubished in Volume: 12
Issue: 5
Pages: m1-m41
Year: May 2024
Downloads: 98
E-ISSN Number: 2320-2882
Fenofibrate is a lipid lowering drug used in the treatment of hyperlipidemia, which is not soluble in water and lower absorption in gastric fluid. In order to improve the solubility and oral absorption of the drug in gastric fluid to enhance solubility of drug by using solid dispersions technique. Solid dispersions of Fenofibrate were prepared and evaluated by using ?-cyclodextrin in different ratios (1:1, 1:2, 1:3, 1:4, 1:5). The effect of kneading method of preparation of solid dispersion on solubility behavior was also investigated. Solid dispersions containing Fenofibrate /?-cyclodextrin formulation provide a promising way to enhance solubilty of fenofibrate. In the formulations of the Fenofibrate and Beta cyclodextrin, Formulation (1:5) shows the great enhance in solubility than pure drug. Beta-cyclodextrin was chosen as the carrier because it has high hydrophilicity, non-toxic, inert, economical. Thus the solubility and bioavailability of fenofibrate was enhanced by the preparation of solid dispersion by kneading method.
Licence: creative commons attribution 4.0
Solubility, Solid Disperion, Fenofibrate,beta cyclodextrin, kneading method.